Evaluation of PC 6 Neiguan With Conventional Acupuncture to Prevent PONV After Laparoscopic Cholecystectomy.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03088696

Enrollment

200

Registered

2017-03-23

Start date

2018-02-01

Completion date

2019-09-01

Last updated

2019-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis, Vomiting, Nausea

Keywords

laparoscopic, acupuncture

Brief summary

Assessment of the effectiveness of PC 6 Neiguan with conventional acupuncture for preventing PONV (PostOperative Nausea and Vomiting) after laparoscopic surgery.

Detailed description

Utilizing acustimulation, the effect of PC 6 Neiguan (acupuncture point Pericardium 6) has been studied in PONV . Conventional acupuncture has not been tested yet in laparoscopic cholecystectomy. The incidence of postoperative vomiting during the first 24 hours is the main outcome. Secondary outcomes include: complete response rate, total rescue ondansetron dose used and patient satisfaction with PONV management.

Interventions

OTHERstimulation

activation of the acupuncture point

OTHERno stimulation

no activation of the acupuncture point

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Outcomes Assessor)

Masking description

The care provider get's an envelope from the study nurse when going to the patient in the operating room. Only the study nurse knows if an acupuncture needle is in the envelope.

Intervention model description

randomized comparative double blind prospective study

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Female and male patients * \> 18 y * General anesthesia * Undergoing laparoscopic surgery * Patient with American Society of Anesthesiologists physical status I-II * Written informed consent

Exclusion criteria

* Pregnant women and breastfeeding * Patient with cardiac disease * Surgery more than 2 h * No bowel surgery * Signs of skin infection at or near the purposed site of the acupuncture point * Patient with American Society of Anesthesiologists physical status IIII-IV

Design outcomes

Primary

Measure	Time frame	Description
Vomiting and Nausea	24 hours	numeric from 0-4, 0= no vomiting, 1= nausea, 2= moderate, 3= multiple and 4= extensive

Secondary

Measure	Time frame	Description
Use of antiemetic	24 hours	dosage in mg
Use of analgesia	24 hours	dosage in mg

Countries

Belgium

Contacts

Primary ContactVeerle Van Mossevelde, Data Nurse

veerle.vanmossevelde@uzbrussel.be+3224763134

Backup ContactDirk De Clippeleir, Data Nurse

dirk.declippeleir@uzbrussel.be+324763580

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026